How is the Mainz Biomed N.V. today?

The Mainz Biomed N.V. today is trading in the down by -10.30% at 2.09.

What is Mainz Biomed N.V. Annual Revenue?

Mainz Biomed N.V. Annual Revenue fell 0.17%, in the last year to $0.89 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Mainz Biomed N.V. Annual Net Profit?

Mainz Biomed N.V. Annual Net Profit rose 17.66% in the last year to $21.65 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Mainz Biomed N.V. Stock Price?

Mainz Biomed N.V. Stock Price fell 91.55% and underperformed its sector by 102.88% in the past year.

What is Mainz Biomed N.V. Debt to Equity Ratio?

Mainz Biomed N.V. Debt to Equity Ratio of 0.54 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Mainz Biomed N.V. Return on Equity(ROE)?

Mainz Biomed N.V. Return on Equity(ROE) for the last financial year was -465.82%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Mainz Biomed N.V. Mutual Fund Holding?

Mainz Biomed N.V. Mutual Fund Holding decreased by 0% in the last quarter to 0.01.

What is Mainz Biomed N.V. Interest Coverage Ratio?

Mainz Biomed N.V. Interest Coverage Ratio is -19.14, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Mainz Biomed N.V. Institutional Holding?

Mainz Biomed N.V. Institutional Holding decreased by 0.86% in the last quarter to 7.22.

Mainz Biomed N.V. XNAS: MYNZ

Mainz Biomed N.V. Live Share Price Today, Share Analysis and Chart

Name: Mainz Biomed N.V.: Is Infosys Ltd. worth buying?
Item: Mainz Biomed N.V.
Rating: 0.67491675
Author: Trendlyne DVM scores

about

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal ca...

2.09 -0.24 (-10.30%)

New 52W Low today

128.2K XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Mainz Biomed N.V. is on 30 May 2025 for the purpose of Mainz Biomed NV Annual General Meeting for 2025 See details

Not Eligible

-

Expensive Valuation

10.7 / 100

Technically Bearish

16.3 / 100

14

1Yr Price target upside is 570%

1 analysts

Mainz Biomed N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mainz Biomed N.V. FAQ

How is Mainz Biomed N.V. today?

Mainz Biomed N.V. today is trading in the red, and is down by -10.30% at 2.09.

How has Mainz Biomed N.V. performed historically?

Mainz Biomed N.V. is currently trading down -10.30% on an intraday basis. In the past week the stock fell -15.38%. stock has been down -62.68% in the past quarter and fell -91.55% in the past year. You can view this in the overview section.